OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Atrial fibrillation therapy with new oral anticoagulants: a real world evidence study
Francesco Ferrara, Ugo Trama, Eduardo Nava, et al.
International Journal of Healthcare Management (2023), pp. 1-4
Closed Access | Times Cited: 11
Francesco Ferrara, Ugo Trama, Eduardo Nava, et al.
International Journal of Healthcare Management (2023), pp. 1-4
Closed Access | Times Cited: 11
Showing 11 citing articles:
Evaluation of biological drug consumption in Italy during 2022: a comparative analysis between two healthcare facilities
Marcello Vaccaro, G. Polito, Gabriele Bagaglini, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access | Times Cited: 1
Marcello Vaccaro, G. Polito, Gabriele Bagaglini, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access | Times Cited: 1
Analysis of biosimilars consumption in an Italian Local Health Authority
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 7
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 7
Antibacterial agents and the fight against antibiotic resistance: A real-world evidence analysis of consumption and spending by an Italian healthcare company
Francesco Ferrara, Maurizio Capuozzo, Roberta Pasquinucci, et al.
Annales Pharmaceutiques Françaises (2024) Vol. 82, Iss. 3, pp. 545-552
Closed Access | Times Cited: 6
Francesco Ferrara, Maurizio Capuozzo, Roberta Pasquinucci, et al.
Annales Pharmaceutiques Françaises (2024) Vol. 82, Iss. 3, pp. 545-552
Closed Access | Times Cited: 6
Monitoring analysis of the use of biosimilar medicines in the Campania region (southern Italy) to support effective and sustainable care
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
Consumption and Expenditure on Drugs Used for Macular Degeneration: An Italian Study of Real-World Evidence
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
SN Comprehensive Clinical Medicine (2025) Vol. 7, Iss. 1
Closed Access
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
SN Comprehensive Clinical Medicine (2025) Vol. 7, Iss. 1
Closed Access
Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance
Francesco Ferrara, Roberta Pasquinucci, Maurizio Capuozzo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 183-183
Open Access | Times Cited: 2
Francesco Ferrara, Roberta Pasquinucci, Maurizio Capuozzo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 183-183
Open Access | Times Cited: 2
Analysis of prescriptive monitoring regarding the current therapeutic landscape of rheumatoid arthritis: the experience of an Italian local health authority
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-7
Closed Access | Times Cited: 1
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-7
Closed Access | Times Cited: 1
The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access | Times Cited: 1
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access | Times Cited: 1
Improving the prescriptive appropriateness of vitamin D: The Italian experience
Francesco Ferrara, Andrea Zovi, Eduardo Nava, et al.
Nutrition Clinique et Métabolisme (2024) Vol. 38, Iss. 2, pp. 95-100
Closed Access
Francesco Ferrara, Andrea Zovi, Eduardo Nava, et al.
Nutrition Clinique et Métabolisme (2024) Vol. 38, Iss. 2, pp. 95-100
Closed Access
Analysis of consumption and expenditure of anti-VEFG drugs used in maculopathies between current events and future prospects
Francesco Ferrara, Maurizio Capuozzo, Roberta Pasquinucci, et al.
Ethics Medicine and Public Health (2024) Vol. 32, pp. 101002-101002
Closed Access
Francesco Ferrara, Maurizio Capuozzo, Roberta Pasquinucci, et al.
Ethics Medicine and Public Health (2024) Vol. 32, pp. 101002-101002
Closed Access
A Short Report on Prescription Monitoring in the Therapeutic Context of Rheumatoid Arthritis at an Italian Local Health Authority
Andrea Zovi, Roberto Langella, Francesco Ferrara
International Journal of Rheumatic Diseases (2024) Vol. 28, Iss. 1
Closed Access
Andrea Zovi, Roberto Langella, Francesco Ferrara
International Journal of Rheumatic Diseases (2024) Vol. 28, Iss. 1
Closed Access
